CROOZ
16.5.2023 05:01:27 CEST | Business Wire | Press release
CROOZ, Inc. (listed on the Tokyo Stock Exchange Standard Market: 2138; head office: Shibuya-ku, Tokyo; the President and CEO: Koji Obuchi; hereinafter "CROOZ") announced that it has officially launched PROJECT XENO, an NFT game developed by the company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230515005017/en/
XENO_TOP (Graphic: Business Wire)
About PROJECT XENO
PROJECT XENO is a blockchain game operated by EPOCH FACTORY and developed by CROOZ, a listed Japanese company. The full-scale tactical battle NFT game combines GameFi, e-Sports, and Fun. PROJECT XENO is available globally and can be played on smartphones and PCs.
PROJECT XENO has the following features.
Feature (1) Collaboration with celebrities such as Floyd Mayweather JR
The game has appointed some ambassadors to reach users around the world; popular YouTuber Hikaru as an ambassador in Japan, along with eight-division boxing world champion Manny Pacquiao and Fumiya, "the most famous Japanese in the Philippines," as ambassadors in Southeast Asia. In addition, NFTs collaborated with former five-division boxing world champion Floyd Mayweather Jr. and others are also available.
Feature (2) Developed by a listed Japanese company
PROJECT XENO is developed and operated by a listed company that has released many hit smartphone games in the Japanese market and is able to provide high-quality games and stable operations.
Feature (3) “Web 2.5” specifications that also enable users without NFT to play
PROJECT XENO is a free-to-play game, meaning that it can still be played by users who do not own NFT. Furthermore, the game supports in-game purchases, allowing users to play the game in exactly the same way as NFT holders. The only difference with NFT holders is the presence or absence of the Earn feature. There are no discrepancies in character strength, etc., allowing PROJECT XENO to be played like any other social game. If social games are Web 2.0 and GameFi games are Web 3.0, then PROJECT XENO can be considered a Web 2.5 game.
About GXE tokens
GXE is a token distributed on PROJECT XENO. GXE is listed on MEXC Global, LBank, BKEX, Bittrex Global, and Gate.io. On May 16, 2023 (Japan time), it was also listed on BITPoint, a crypto asset exchange of the SBI Group based in Tokyo, Japan. BITPoint has been approved as a crypto asset exchange operator by the Japanese Financial Services Agency.
The latest information on PROJECT XENO
For more information on PROJECT XENO, visit the website.
Up-to-date information is also available on Twitter.
- PROJECT XENO: http://project-xeno.com/
- PROJECT XENO Official Twitter: https://twitter.com/PROJECTXENO_GLB
About CROOZ, Inc.
With the fashion shopping site "SHOPLIST.com by CROOZ" at its core, CROOZ, Inc. develops a wide range of Internet services in the entertainment domain, including shopping and games, always in step with the changing times.
https://crooz.co.jp
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005017/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom